相关实验视频
Updated: Sep 11, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
在慢性病中NRF2失调和治疗见解
Tina Si Ting Lim1,2, Kar Hui Ng1,2, Yaochun Zhang1,2
1Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117549, Singapore.
核因素红色素2相关因子2 (NRF2) 在慢性病 (CKD) 亚型中表现出多样化的活性. 将NRF2调制定制为特定的CKD环境对于有效的治疗策略至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 是一个重大的全球健康挑战,其核心机制受到有限的治疗.
- 核因素红色素2相关因子2 (NRF2) 是细胞对氧化应激和炎症反应的关键调节者,使其成为CKD的一个有希望的治疗点.
- 尽管临床前有希望,但没有NRF2向药物获得了对CKD的临床批准.
研究的目的:
- 审查和综合有关不同类型的CKD中NRF2活性异质性的现有证据.
- 探索NRF2调制在不同CKD病因和阶段的治疗影响.
- 突出特定于背景的NRF2向对于有效的CKD治疗和药物开发的重要性.
主要方法:
- 文献综述和关于CKD中NRF2的临床前和临床数据的综合.
- 基于CKD病因,阶段和进展率的NRF2活动变化的分析.
- 评估NRF2过度激活和随意激活在不同CKD环境中的后果.
主要成果:
- NRF2活性在CKD亚型中表现出显著的异质性,受疾病原因,阶段和进展的影响.
- 作为一种治疗策略,NRF2激活的有效性高度依赖于根据特定疾病背景量身定制的精确调制.
- 无差别的NRF2激活可以有不同的效果,这取决于CKD的病因和细胞环境.
结论:
- 有细微差别的,特定于背景的方法对于开发有效的NRF2向治疗CKD至关重要.
- 了解NRF2活动的异质性是指导未来脏病学药物开发策略的关键.
- 未来的研究应该专注于精确调节NRF2通路,以适应个体CKD患者的个人资料和疾病特征.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Nephrons
Acute Kidney Injury IV: Diagnostic Studies and Prevention